We are pleased to announce that the 2021 winner is Daniel Gleghorn from Addenbrookes Hospital in Cambridge. We were looking for nominations for individuals who have championed clinical viscosity testing and really taken it forward. Out of all the nominations we received, the stand-out person was Daniel who led the research team within the Cambridge University Hospital NHS Foundation in a study into the diagnostic value of plasma viscosity testing for patients with COVID-19.

The research demonstrated a sensitive and original use of plasma viscosity in the risk stratification of patients with COVID‐19 infection. This research could change the way we manage the pandemic and help to quickly categorize patients with suspected symptoms of COVID‐19 into high or low disease complication risk groups. The research was published in the International Journal of Laboratory Hematology.

We are looking forward to Daniel being able to accept his prize. With COVID restrictions still in place we’ve not been able to set a date but will arrange a presentation as soon as practical and safe to do so.

Well done Daniel!

For more information on Daniel’s research, and to see the paper, just click here